GID BIO IN THE NEWS

Read how recent cell-based therapy discoveries are impacting the field of medicine.

Cell Therapy News

6 Orthobiologic Companies Move Clinical Trials Forward

Multiple orthobiologic companies have engaged in clinical trials in 2019, seeking to demonstrate the efficacy of their cell-based products…. GID BIO completed a multi-site, randomized, placebo-controlled Phase IIb clinical trial with an FDA-approved study design using autologous stromal cells in the treatment of knee osteoarthritis (OA), successfully meeting endpoints and two-year safety results…

Learn More »
✉ RECEIVE OUR NEWSLETTER   
Scroll to Top